Prashant Vempati

1.3k total citations
22 papers, 1.0k citations indexed

About

Prashant Vempati is a scholar working on Physiology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Prashant Vempati has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Oncology and 5 papers in Otorhinolaryngology. Recurrent topics in Prashant Vempati's work include Alzheimer's disease research and treatments (7 papers), Head and Neck Cancer Studies (5 papers) and Cancer Diagnosis and Treatment (3 papers). Prashant Vempati is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Head and Neck Cancer Studies (5 papers) and Cancer Diagnosis and Treatment (3 papers). Prashant Vempati collaborates with scholars based in United States, Japan and Austria. Prashant Vempati's co-authors include Giulio Maria Pasinetti, Wei Zhao, Lap Ho, Jun Wang, Bing Gong, Yong Pan, Lindsay Knable, Alice Cheng, Kenjiro Ono and Anthony A. Sauve and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Prashant Vempati

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashant Vempati United States 12 420 325 163 157 141 22 1.0k
Xiaodong Xue China 20 230 0.5× 627 1.9× 149 0.9× 162 1.0× 73 0.5× 46 1.4k
Lora C. Bailey‐Downs United States 14 371 0.9× 566 1.7× 46 0.3× 145 0.9× 80 0.6× 26 1.4k
Ravinder K. Kaundal India 22 350 0.8× 449 1.4× 110 0.7× 80 0.5× 139 1.0× 54 1.2k
Byung Yong Rhim South Korea 21 330 0.8× 421 1.3× 51 0.3× 141 0.9× 83 0.6× 37 1.2k
Cristina Parrado‐Fernández Sweden 15 410 1.0× 454 1.4× 49 0.3× 81 0.5× 75 0.5× 18 1.0k
Emilie Vessières France 21 337 0.8× 546 1.7× 106 0.7× 112 0.7× 68 0.5× 46 1.3k
Dayun Feng China 19 185 0.4× 620 1.9× 90 0.6× 333 2.1× 213 1.5× 26 1.4k
Aparna Areti India 16 515 1.2× 378 1.2× 57 0.3× 78 0.5× 121 0.9× 22 1.3k
Hean Zhuang United States 19 187 0.4× 668 2.1× 140 0.9× 72 0.5× 165 1.2× 20 1.2k
Pallavi Chandakkar United States 12 481 1.1× 456 1.4× 177 1.1× 299 1.9× 148 1.0× 16 1.2k

Countries citing papers authored by Prashant Vempati

Since Specialization
Citations

This map shows the geographic impact of Prashant Vempati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Vempati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Vempati more than expected).

Fields of papers citing papers by Prashant Vempati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Vempati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Vempati. The network helps show where Prashant Vempati may publish in the future.

Co-authorship network of co-authors of Prashant Vempati

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Vempati. A scholar is included among the top collaborators of Prashant Vempati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Vempati. Prashant Vempati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahajan, Anita, Helen A. Shih, Christina Tsien, et al.. (2025). Signal-Seeking P2R Trial of Proton or IMRT Dose Intensification in GBM: NRG-BN001. International Journal of Radiation Oncology*Biology*Physics. 123(4). 1204–1204.
3.
Vempati, Prashant, et al.. (2023). Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study. Clinical Lung Cancer. 24(6). e198–e204. 4 indexed citations
4.
Gogineni, Emile, Zaker Rana, Prashant Vempati, et al.. (2020). Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer. Head & Neck. 42(10). 2880–2886. 11 indexed citations
5.
Vempati, Prashant, Sewit Teckie, Zaker Rana, et al.. (2020). Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer. Radiation Oncology. 15(1). 278–278. 6 indexed citations
6.
Vempati, Prashant, et al.. (2020). A Potential Synergistic Role of Radiation Therapy with Targeting of the CCL2 – CCR2 Signaling Axis in a Murine Model of Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). e554–e555. 1 indexed citations
7.
Gogineni, Emile, Zaker Rana, Prashant Vempati, et al.. (2019). Stereotactic Body Radiotherapy as Primary Treatment for Medically Unfit Patients with Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(1). E399–E400. 1 indexed citations
8.
Steinberger, Jeremy, Rachel S. Bronheim, Prashant Vempati, et al.. (2017). Morbidity and Mortality of Meningioma Resection Increases in Octogenarians. World Neurosurgery. 109. e16–e23. 36 indexed citations
9.
Vempati, Prashant, Miriam A. Knoll, Kavita V. Dharmarajan, et al.. (2016). Palliation of Ulcerative Breast Lesions with Radiation. Anticancer Research. 36(9). 4701–4706. 20 indexed citations
10.
Sayan, Mutlay, Prashant Vempati, Brett A. Miles, et al.. (2016). Adjuvant Therapy for Salivary Gland Carcinomas.. PubMed. 36(8). 4165–70. 9 indexed citations
11.
Vempati, Prashant, et al.. (2015). MALT Lymphoma of the Bladder: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2015. 1–7. 9 indexed citations
12.
Wang, Jun, Kenjiro Ono, Jorge Gálvez, et al.. (2014). Molecular Topology as Novel Strategy for Discovery of Drugs with Aβ Lowering and Anti-Aggregation Dual Activities for Alzheimer’s Disease. PLoS ONE. 9(3). e92750–e92750. 13 indexed citations
13.
Wang, Jun, Weina Bi, Alice Cheng, et al.. (2014). Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications. Frontiers in Aging Neuroscience. 6. 42–42. 94 indexed citations
15.
Wang, Jun, Zhong Zhao, Wei Zhao, et al.. (2013). Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer’s Disease. PLoS ONE. 8(6). e65232–e65232. 26 indexed citations
16.
Gong, Bing, Yong Pan, Wei Zhao, et al.. (2013). IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway. Molecular Immunology. 56(4). 619–629. 35 indexed citations
17.
Wang, Jun, Bing Gong, Wei Zhao, et al.. (2013). Epigenetic Mechanisms Linking Diabetes and Synaptic Impairments. Diabetes. 63(2). 645–654. 46 indexed citations
18.
Zhao, Wei, Merina Varghese, Prashant Vempati, et al.. (2012). Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease. PLoS ONE. 7(11). e49191–e49191. 103 indexed citations
19.
Zhao, Wei, Merina Varghese, Shrishailam Yemul, et al.. (2011). Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Molecular Neurodegeneration. 6(1). 51–51. 107 indexed citations
20.
Scherer, Thomas, James O’Hare, Kelly A. Diggs‐Andrews, et al.. (2011). Brain Insulin Controls Adipose Tissue Lipolysis and Lipogenesis. Cell Metabolism. 13(2). 183–194. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026